Rakovina Therapeutics Balance Sheet Health
Financial Health criteria checks 2/6
Rakovina Therapeutics has a total shareholder equity of CA$4.3M and total debt of CA$1.3M, which brings its debt-to-equity ratio to 30.4%. Its total assets and total liabilities are CA$5.8M and CA$1.5M respectively.
Key information
30.4%
Debt to equity ratio
CA$1.31m
Debt
Interest coverage ratio | n/a |
Cash | CA$813.33k |
Equity | CA$4.33m |
Total liabilities | CA$1.50m |
Total assets | CA$5.82m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: RKV's short term assets (CA$1.2M) exceed its short term liabilities (CA$183.7K).
Long Term Liabilities: RKV's short term assets (CA$1.2M) do not cover its long term liabilities (CA$1.3M).
Debt to Equity History and Analysis
Debt Level: RKV's net debt to equity ratio (11.6%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if RKV's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: RKV has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: RKV has less than a year of cash runway if free cash flow continues to reduce at historical rates of 39.7% each year